Piramal Phamra reports Q2 FY23 consolidated loss at Rs. 37.34 Cr
News

Piramal Phamra reports Q2 FY23 consolidated loss at Rs. 37.34 Cr

  • By IPP Bureau | November 09, 2022

Piramal Pharma Limited has posted net loss of Rs. 37.34 crores for the period ended September 30, 2022 as against net loss of Rs. 109.05 crores for the period ended June 30, 2022. The company posted net profit of Rs.36.56 crores for the period ended September 30, 2021.

The company has reported total income of Rs. 1766.23 crores during the period ended September 30, 2022 as compared to Rs. 1553.84 crores during the period ended June 30, 2022. The company reported total income of Rs.1595.45 crores during the period ended September 30, 2021. 

For the half year ended Sept 30, 2022, Piramal Phamra reported total income of Rs.3320.07 croresas compared to Rs.2925.72 crores during the corresponding period ended September 30, 2021.

The company has posted net loss of Rs.146.39 crores for the 6 months period ended September 30, 2022 as against net profit of Rs.8.53 crores for the 6 Months period ended September 30, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization